EMEA-002908-PIP02-22
Submitted by Anonymous (not verified) on 15 July 2024 - 16:38
EMEA-002908-PIP02-22
EMEA-002559-PIP08-23
Submitted by Anonymous (not verified) on 15 July 2024 - 16:32
EMEA-002559-PIP08-23
Opinion/decision on a Paediatric investigation plan (PIP): Spevigo, Spesolimab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Dermatology, PIP number: P/0247/2023
Submitted by Anonymous (not verified) on 15 July 2024 - 16:26
Opinion/decision on a Paediatric investigation plan (PIP): Spevigo, Spesolimab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Dermatology, PIP number: P/0247/2023
Post-authorisation measures (recommendations, conditions and specific obligations): veterinary medicines
Submitted by Anonymous (not verified) on 15 July 2024 - 15:26
Post-authorisation measures (recommendations, conditions and specific obligations): veterinary medicines
Agenda of the CVMP meeting 16-18 July 2024
Submitted by Anonymous (not verified) on 15 July 2024 - 14:29
Agenda of the CVMP meeting 16-18 July 2024
Table of decisions of labelling exemption requests falling under article 63 of Directive 2001/83/EC examined by the Quality Review of Documents (QRD) Group
Submitted by Anonymous (not verified) on 15 July 2024 - 10:59
Table of decisions of labelling exemption requests falling under article 63 of Directive 2001/83/EC examined by the Quality Review of Documents (QRD) Group
Applications for new human medicines under evaluation: July 2024
Submitted by Anonymous (not verified) on 15 July 2024 - 10:29
Applications for new human medicines under evaluation: July 2024
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 22 May 2024, 10:00 (CEST) to 22 May 2024, 13:30 (CEST)
Submitted by Anonymous (not verified) on 15 July 2024 - 10:26
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 22 May 2024, 10:00 (CEST) to 22 May 2024, 13:30 (CEST)
Meeting summary - Medicine Shortages SPOC Working Party meeting on 22 May 2024
Submitted by Anonymous (not verified) on 15 July 2024 - 10:25
Meeting summary - Medicine Shortages SPOC Working Party meeting on 22 May 2024
Opinion/decision on a Paediatric investigation plan (PIP): Sotyktu, Deucravacitinib, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Immunology-Rheumatology-Transplantation, PIP number: P
Submitted by Anonymous (not verified) on 12 July 2024 - 16:20
Opinion/decision on a Paediatric investigation plan (PIP): Sotyktu, Deucravacitinib, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Immunology-Rheumatology-Transplantation, PIP number: P/0250/2023